Vertex Pharmaceuticals (Germany) Technical Analysis

VX1 Stock  EUR 429.45  5.60  1.32%   
As of the 23rd of November, Vertex Pharmaceuticals has the Risk Adjusted Performance of 0.0057, variance of 3.5, and Coefficient Of Variation of (484,970). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vertex Pharmaceuticals, as well as the relationship between them. Please validate Vertex Pharmaceuticals mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Vertex Pharmaceuticals is priced more or less accurately, providing market reflects its prevalent price of 429.45 per share.

Vertex Pharmaceuticals Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Vertex, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Vertex
  
Vertex Pharmaceuticals' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Vertex Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Vertex Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vertex Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Vertex Pharmaceuticals Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Vertex Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Vertex Pharmaceuticals Trend Analysis

Use this graph to draw trend lines for Vertex Pharmaceuticals Incorporated. You can use it to identify possible trend reversals for Vertex Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Vertex Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Vertex Pharmaceuticals Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Vertex Pharmaceuticals Incorporated applied against its price change over selected period. The best fit line has a slop of   0.49  , which means Vertex Pharmaceuticals Incorporated will continue generating value for investors. It has 122 observation points and a regression sum of squares at 8981.58, which is the sum of squared deviations for the predicted Vertex Pharmaceuticals price change compared to its average price change.

About Vertex Pharmaceuticals Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Vertex Pharmaceuticals Incorporated on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Vertex Pharmaceuticals Incorporated based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Vertex Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Vertex Pharmaceuticals. By analyzing Vertex Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Vertex Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Vertex Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.

Vertex Pharmaceuticals November 23, 2024 Technical Indicators

Most technical analysis of Vertex help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Vertex from various momentum indicators to cycle indicators. When you analyze Vertex charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stocks Directory
Find actively traded stocks across global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories